The following table details the trading activities
(stock purchases, stock sales, and stock option exercises)
the Securities and Exchange Commission (SEC)
by insider Azelby Robert since year 2005.
The trader's CIK number is 1656998.
At the time of this reporting, Azelby Robert is the EVP & Chief Commercial Officer of Juno Therapeutics, Inc. .
(stock ticker symbol JUNO).
See this page for all insider trading activities at Juno Therapeutics, Inc. .
|Trade Date||Symbol||Company Name (Issuer)||Trade Type||Shares||Price ($)||Value ($)|
|2017-11-02||JUNO||Juno Therapeutics, Inc.||Sale||6,666||54.95||366,296|
|2017-11-02||JUNO||Juno Therapeutics, Inc.||Option Ex||6,666||25.29||168,583|
|2017-09-13||JUNO||Juno Therapeutics, Inc.||Sale||12,850||44.95||577,607|
|2017-08-29||JUNO||Juno Therapeutics, Inc.||Sale||12,869||39.95||514,116|
|2016-11-10||JUNO||Juno Therapeutics, Inc.||Sale||12,921||24.14||311,848|
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Azelby Robert (EVP & Chief Commercial Officer of Juno Therapeutics, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.